UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 122

Sortiert nach

Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection

Nature (London), 2013-10, Vol.502 (7472), p.559-562

2013

Link zum Volltext

Verfügbarkeit prüfen

Human MxB Protein Is a Pan-herpesvirus Restriction Factor

Journal of virology, 2018-09, Vol.92 (17)

2018

Link zum Volltext

Verfügbarkeit prüfen

Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly

PLoS pathogens, 2008-03, Vol.4 (3), p.e1000035-e1000035

2008

Link zum Volltext

Verfügbarkeit prüfen

CPSF6 defines a conserved capsid interface that modulates HIV-1 replication

PLoS pathogens, 2012-08, Vol.8 (8), p.e1002896-e1002896

2012

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency

PLoS pathogens, 2011-12, Vol.7 (12), p.e1002439-e1002439

2011

Link zum Volltext

Verfügbarkeit prüfen

SAMHD1 protects cancer cells from various nucleoside-based antimetabolites

Cell cycle (Georgetown, Tex.), 2017-06, Vol.16 (11), p.1029-1038

2017

Link zum Volltext

Verfügbarkeit prüfen

Analysis of Hepatitis C Virus Superinfection Exclusion by Using Novel Fluorochrome Gene-Tagged Viral Genomes

Journal of Virology, 2007-05, Vol.81 (9), p.4591-4603

2007

Link zum Volltext

Verfügbarkeit prüfen

Promiscuous RNA binding ensures effective encapsidation of APOBEC3 proteins by HIV-1

PLoS pathogens, 2015-01, Vol.11 (1), p.e1004609-e1004609

2015

Link zum Volltext

Verfügbarkeit prüfen

Affinity Polymers Tailored for the Protein A Binding Site of Immunoglobulin G Proteins

Chemistry : a European journal, 2014-09, Vol.20 (36), p.11479-11487

2014

Link zum Volltext

Verfügbarkeit prüfen

Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion

PLoS pathogens, 2009-05, Vol.5 (5), p.e1000443-e1000443

2009

Link zum Volltext

Verfügbarkeit prüfen

Complex Interplay between HIV-1 Capsid and MX2-Independent Alpha Interferon-Induced Antiviral Factors

Journal of virology, 2016-08, Vol.90 (16), p.7469-7480

2016

Link zum Volltext

Verfügbarkeit prüfen

HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2

PLoS pathogens, 2011-03, Vol.7 (3), p.e1001313-e1001313

2011

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 capsid undergoes coupled binding and isomerization by the nuclear pore protein NUP358

Retrovirology, 2013-07, Vol.10 (1), p.81-81, Article 81

2013

Link zum Volltext

Verfügbarkeit prüfen

High-Affinity Copolymers Inhibit Digestive Enzymes by Surface Recognition

Biomacromolecules, 2017-06, Vol.18 (6), p.1772-1784

2017

Link zum Volltext

Verfügbarkeit prüfen

Active site remodeling switches HIV specificity of antiretroviral TRIMCyp

Nature structural & molecular biology, 2009-10, Vol.16 (10), p.1036-1042

2009

Link zum Volltext

Verfügbarkeit prüfen

The Early Bird Catches the Worm--Can Evolution Teach us Lessons in Fighting HIV?

Current HIV research, 2016-01, Vol.14 (3), p.183

2016

Link zum Volltext

Verfügbarkeit prüfen

An Active TRIM5 Protein in Rabbits Indicates a Common Antiviral Ancestor for Mammalian TRIM5 Proteins

Journal of Virology, 2007-11, Vol.81 (21), p.11713-11721

2007

Link zum Volltext

Verfügbarkeit prüfen

First‐in‐human, randomized, double‐blind, placebo‐controlled, dose escalation trial of the anti‐herpes simplex virus monoclonal antibody HDIT101 in healthy volunteers

Clinical and translational science, 2022-10, Vol.15 (10), p.2366-2377

2022

Link zum Volltext

Verfügbarkeit prüfen

Cyclophilin A Levels Dictate Infection Efficiency of Human Immunodeficiency Virus Type 1 Capsid Escape Mutants A92E and G94D

Journal of Virology, 2009-02, Vol.83 (4), p.2044-2047

2009

Link zum Volltext

Verfügbarkeit prüfen

Truncation of TRIM5 in the Feliformia Explains the Absence of Retroviral Restriction in Cells of the Domestic Cat

Journal of Virology, 2009-08, Vol.83 (16), p.8270-8275

2009

Link zum Volltext

Verfügbarkeit prüfen

SAMHD1 is a barrier to antimetabolite-based cancer therapies

Molecular & cellular oncology, 2017-01, Vol.4 (2), p.e1287554-e1287554

2017

Link zum Volltext

Verfügbarkeit prüfen

Development and Validation of an LC–MS-Based Quantification Assay for New Therapeutic Antibodies: Application to a Novel Therapy against Herpes Simplex Virus

ACS omega, 2020-09, Vol.5 (38), p.24329-24339

2020

Link zum Volltext

Verfügbarkeit prüfen

Hare TRIM5α Restricts Divergent Retroviruses and Exhibits Significant Sequence Variation from Closely Related Lagomorpha TRIM5 Genes

Journal of Virology, 2010-12, Vol.84 (23), p.12463-12468

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 122

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(117)
Mit Volltextzugriff
(117)

Publikationsform

Artikel
(122)

Sprache

Englisch
(117)
Japanisch
(21)
Deutsch
(4)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection

Human MxB Protein Is a Pan-herpesvirus Restriction Factor

Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly

CPSF6 defines a conserved capsid interface that modulates HIV-1 replication

HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency

SAMHD1 protects cancer cells from various nucleoside-based antimetabolites

Analysis of Hepatitis C Virus Superinfection Exclusion by Using Novel Fluorochrome Gene-Tagged Viral Genomes

Promiscuous RNA binding ensures effective encapsidation of APOBEC3 proteins by HIV-1

Affinity Polymers Tailored for the Protein A Binding Site of Immunoglobulin G Proteins

Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion

Complex Interplay between HIV-1 Capsid and MX2-Independent Alpha Interferon-Induced Antiviral Factors

HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2

HIV-1 capsid undergoes coupled binding and isomerization by the nuclear pore protein NUP358

Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy

Development of a chemical probe against NUDT15

High-Affinity Copolymers Inhibit Digestive Enzymes by Surface Recognition

Active site remodeling switches HIV specificity of antiretroviral TRIMCyp

The Early Bird Catches the Worm--Can Evolution Teach us Lessons in Fighting HIV?

An Active TRIM5 Protein in Rabbits Indicates a Common Antiviral Ancestor for Mammalian TRIM5 Proteins

First‐in‐human, randomized, double‐blind, placebo‐controlled, dose escalation trial of the anti‐herpes simplex virus monoclonal antibody HDIT101 in healthy volunteers

Cyclophilin A Levels Dictate Infection Efficiency of Human Immunodeficiency Virus Type 1 Capsid Escape Mutants A92E and G94D

Truncation of TRIM5 in the Feliformia Explains the Absence of Retroviral Restriction in Cells of the Domestic Cat

SAMHD1 is a barrier to antimetabolite-based cancer therapies

Development and Validation of an LC–MS-Based Quantification Assay for New Therapeutic Antibodies: Application to a Novel Therapy against Herpes Simplex Virus

Hare TRIM5α Restricts Divergent Retroviruses and Exhibits Significant Sequence Variation from Closely Related Lagomorpha TRIM5 Genes

Suchergebnisse filtern